These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26614)

  • 21. [Thymus-dependence of genetic resistance to (CBA x M523)F1 lymphocytes].
    Kondrat'eva TK; Novikova TK; Fontalin LN; Kondrat'eva IA; Blandova ZK
    Biull Eksp Biol Med; 1983 Mar; 95(3):73-5. PubMed ID: 6338962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of asialo-GM1+ cells from the F1 recipient mice prior to irradiation and transfusion of parental spleen cells prevents mortality to acute graft-versus-host disease and induction of anti-host specific cytotoxic T cells.
    Varkila K
    Clin Exp Immunol; 1987 Sep; 69(3):652-9. PubMed ID: 3499271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant.
    Schwartz RH; Fathman CG; Sachs DH
    J Immunol; 1976 Apr; 116(4):929-35. PubMed ID: 56405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of graft-versus-host reaction in rats by cell-free extract from heterologous liver.
    Skowron-Cendrzak A; Plonkowa I; Rybczyńska Z; Kowalczyk K; Turowski G
    Arch Immunol Ther Exp (Warsz); 1974; 22(4):457-66. PubMed ID: 4153987
    [No Abstract]   [Full Text] [Related]  

  • 29. Similarity of cellular recognition structures for histocompatibility antigens and of combining sites of corresponding alloantibodies.
    Ramseier H; Lindenmann J
    Eur J Immunol; 1972 Apr; 2(2):109-14. PubMed ID: 4118769
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiocurability of a transplantable murine sarcoma as influenced by immune competence of the host and adjuvant active specific immunotherapy.
    Deneufbourg JM
    Strahlentherapie; 1975 Apr; 149(4):457-62. PubMed ID: 237344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 35. [The influence of the graft versus host reaction on the growth of syngenous sarcoma in mice].
    Shcherbakov VIa; Semenkov VF
    Biull Eksp Biol Med; 1973 Feb; 74(2):70-3. PubMed ID: 4155646
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
    Hamilton BL; Bevan MJ; Parkman R
    J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adoptive transfer of tumour homograft immunity by lymph node cells undergoing graft-versus-host reaction.
    Medzihradský J; Klobusická M; Koníková E; Babusíková O
    Neoplasma; 1971; 18(3):233-40. PubMed ID: 4398444
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo lymphocyte transformation induced by differences at non-H-2 loci.
    Popp DM; Davis ML
    Transplant Proc; 1971 Mar; 3(1):187-91. PubMed ID: 4106306
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between foreign H-2-like antigens on MCG4 sarcoma and the in vivo rejection of this tumor by syngeneic and semisyngeneic mice.
    García-Olivares E; Torres MD; Gutiérrez F; Osorio C
    Rev Esp Fisiol; 1982 Mar; 38(1):9-12. PubMed ID: 7100610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of the intensification of the immune response to Staphylococcus in mice after the transplantation of primed donor splenocytes].
    Bobrovnik SA; Liashchenko KP
    Biull Eksp Biol Med; 1985 Jul; 100(7):49-51. PubMed ID: 4040404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.